首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1274356

小型静脉曲张硬化疗法全球市场研究报告-2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Microsclerotherapy Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 126 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球对小静脉曲张硬化剂市场的需求预计将从 2022 年的 110.2 亿美元增长到 2030 年的近 177.2 亿美元，2023-2030 年研究期间的复合年增长率为 6.12%。预计将达到市场尺寸。

小静脉曲张硬化疗法是一种微创医疗程序，可治疗小静脉曲张和蜘蛛状静脉。这是一种硬化疗法，其中将硬化溶液注入受影响的静脉。静脉会收缩并最终消失。微硬化疗法是治疗小静脉曲张和蜘蛛状静脉的有效方法，与传统手术治疗相比具有多种优势，包括恢復时间更短、并发症风险更低以及美容效果更佳。还有一些优势。

市场动态：

以静脉肿胀和扭曲为特征的静脉曲张的患病率不断增加，这推动了对小静脉曲张进行硬化疗法治疗的需求。这种微创手术是治疗静脉曲张和改善腿部外观的有效方法。对小静脉曲张硬化疗法的可用性和有效性的认识不断提高，这推动了对该程序的需求。随着意识的提高，越来越多的人正在寻求治疗静脉曲张和其他相关疾病的方法。此外，先进的静脉曲张硬化治疗技术和设备的发展，如超声引导硬化治疗和泡沫硬化治疗，正在推动市场增长。这些进步提高了手术的准确性和有效性，使其成为静脉曲张的流行治疗选择。微创手术的兴起和医疗旅游业的增长正在推动对小静脉曲张硬化治疗市场的需求。患者在国外、治疗更便宜的国家和专门从事医疗旅游的国家寻求治疗。

研究报告描述了波特的五力模型、市场吸引力分析和价值链分析。这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。此外，这些工具还可以对全球静脉曲张硬化疗法市场的每个细分市场进行全面评估。小静脉曲张硬化疗法行业的发展和趋势为这项研究提供了一种整体方法。

市场细分：

此部分通过提供有关国家和地区细分的详细数据，帮助战略制定者确定每种产品或服务的目标受众并抓住未来的机会。

按产品类型

固化剂
十四烷基硫酸钠
聚多卡醇
铬甘油
高渗葡萄糖
针
其他

由最终用户

医院
美容医学诊所
其他

按地区分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲微硬化市场当前和未来的需求。此外，我们还关注所有主要地区每个单独应用领域的需求、估计和预测。

这份研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。小型静脉曲张硬化剂市场的主要参与者是 Merz Pharma GmbH &Co.KGaA、Surgimedix Inc、Troikaa、QOL Medical LLC、McKesson Corporation、Kreussler Inc、Provensis、ltd、Omega Pharmaceuticals、STD Pharmaceuticals Product Ltd、Medtronic Plc、Endo-Flex、波士顿科学公司和泰利福公司。本节概述了竞争格局，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。

如果您有定制要求，请联繫我们。我们的研究团队可以根据您的需要提供定制报告。

内容

第一章前言

本报告的内容
- 目的
- 目标受众
- 独特的销售主张 (USP) 及其提供的内容
调查范围
调查方法
- 市场调研过程
- 市场研究方法

第 2 章执行摘要

市场亮点
全球市场概况

第 3 章小静脉曲张硬化剂 - 行业分析

简介 - 市场动态
市场驱动因素
市场製约因素
商机
行业趋势
波特的五力分析
市场吸引力分析
- 市场吸引力分析：按产品类型
- 按市场进行的吸引力分析：按最终用户
- 市场吸引力分析：按地区

第四章价值链分析

价值链分析
原材料分析
- 成分錶
- 原材料製造商列表
- 主要原材料价格走势
潜在买家名单
营销渠道
- 直接营销
- 间接营销
- 营销渠道趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章按产品类型分列的小型静脉曲张硬化剂全球市场分析

摘要：按产品类型
实际数据和预测数据
分析：按产品类型
固化剂
十四烷基硫酸钠
聚多卡醇
铬甘油
高渗葡萄糖
针
其他

第 7 章小静脉曲张硬化疗法的全球市场分析：按最终用户分类

最终用户总结
实际数据和预测数据
最终用户分析
医院
美容医学诊所
其他

第 8 章小型静脉曲张硬化疗法的全球市场分析：按地区

区域展望
简介
北美销售分析
- 概览、历史和预测销售分析
- 北美各部门的销售分析
- 北美销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史和预测销售分析
- 按细分市场进行的欧洲销售分析
- 按国家/地区划分的欧洲销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 其他欧洲销售分析
亚太地区销售分析
- 概览、历史和未来销售分析
- 亚太地区各部门的销售分析
- 亚太国家/地区销售分析
- 在中国的销售分析
- 印度销售分析
- 日本的销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 其他亚太地区销售分析
拉丁美洲销售分析
- 概览、历史和未来销售分析
- 拉丁美洲各部门的销售分析
- 拉丁美洲国家/地区的销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利的销售分析
- 其他拉丁美洲销售分析
中东和非洲销售分析
- 概览、历史和未来销售分析
- 中东/非洲地区的销售分析
- 中东和非洲国家/地区的销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 其他中东和非洲销售分析

第9章小静脉曲张硬化药企业的竞争格局

小静脉曲张硬化剂的市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第十章公司简介

顶级公司的市场份额分析
市场集中度
Merz Pharma GmbH & Co. KGaA
- 公司简介
- 企业收入
- 产品介绍
- 近期发展状况
Surgimedix Inc.
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
三驾马车
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
QOL 医疗有限责任公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
麦克森公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
克鲁斯勒公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
Provensis 有限公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
欧米茄製药
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
STD 製药产品有限公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
美敦力公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
Endo-Flex
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
波士顿科学公司
- 公司简介
- 企业收入
- 产品信息
- 近期发展状况
Teleflex 公司。
- 公司简介
- 企业收入
- 产品信息
- 近期趋势

注意：公司简介中的财务细节和近期发展基于可用信息，可能不包括私营公司。

简介目录图表

Product Code: VMR112110461

The global demand for Microsclerotherapy Treatment Market is presumed to reach the market size of nearly USD 17.72 BN by 2030 from USD 11.02 BN in 2022 with a CAGR of 6.12% under the study period 2023 - 2030.

Microsclerotherapy is a minimally invasive medical procedure and treats small varicose veins and spider veins. It is a form of sclerotherapy, a procedure that involves the injection of a sclerosing solution to the affected veins. It helps the veins to shrink and eventually disappear. Microsclerotherapy is an effective treatment option for small varicose veins and spider veins, and it offers several advantages over traditional surgical treatments, including faster recovery time, lower risk of complications, and improved cosmetic results.

Market Dynamics:

The increasing prevalence of varicose veins, a condition characterized by swollen and twisted veins, is driving the demand for microsclerotherapy treatment. This minimally invasive procedure is an effective way to treat varicose veins and improve the appearance of the legs. The growing awareness about the availability and effectiveness of microsclerotherapy treatment is driving the demand for the procedure. With increased awareness, more people are seeking treatment for varicose veins and other related conditions. Moreover, the development of advanced microsclerotherapy techniques and equipment, such as ultrasound-guided microsclerotherapy and foam sclerotherapy, is pushing the growth of the market uphill. These advancements have improved the accuracy and effectiveness of the procedure, making it a popular treatment option for varicose veins. The increase in minimally invasive procedures and the growing medical tourism industry is driving the microsclerotherapy treatment market demand. Patients are seeking treatment abroad in countries where the procedure is less expensive, or in countries that specialize in medical tourism.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of microsclerotherapy treatment. The growth and trends of microsclerotherapy treatment industry provide a holistic approach to this study.

Market Segmentation:

This section of the microsclerotherapy treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Sclerosants
Sodium Tetradecyl Sulphate
Polidocanol
Chromated Glycerin
Hypertonic Glucose
Needles
Others

By End Users

Hospitals
Aesthetic Treatment Clinics
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Microsclerotherapy Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the microsclerotherapy treatment market include Merz Pharma GmbH & Co. KGaA, Surgimedix Inc, Troikaa, QOL Medical LLC, McKesson Corporation, Kreussler Inc, Provensis, ltd, Omega Pharmaceuticals, STD Pharmaceuticals Product Ltd, Medtronic Plc, Endo-Flex, Boston Scientific Corporation, and Teleflex Incorporated. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . MICROSCLEROTHERAPY TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By End Users
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MICROSCLEROTHERAPY TREATMENT MARKET ANALYSIS BY PRODUCT TYPE

6.1 Overview by Product Type
6.2 Historical and Forecast Data
6.3 Analysis by Product Type
6.4 Sclerosants Historic and Forecast Sales by Regions
6.5 Sodium Tetradecyl Sulphate Historic and Forecast Sales by Regions
6.6 Polidocanol Historic and Forecast Sales by Regions
6.7 Chromated Glycerin Historic and Forecast Sales by Regions
6.8 Hypertonic Glucose Historic and Forecast Sales by Regions
6.9 Needles Historic and Forecast Sales by Regions
6.10. Others Historic and Forecast Sales by Regions

7 . GLOBAL MICROSCLEROTHERAPY TREATMENT MARKET ANALYSIS BY END USERS

7.1 Overview by End Users
7.2 Historical and Forecast Data
7.3 Analysis by End Users
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Aesthetic Treatment Clinics Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL MICROSCLEROTHERAPY TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MICROSCLEROTHERAPY TREATMENT COMPANIES

9.1. Microsclerotherapy Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF MICROSCLEROTHERAPY TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Merz Pharma GmbH & Co. KGaA
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Surgimedix Inc
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Troikaa
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. QOL Medical LLC
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. McKesson Corporation
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Kreussler Inc
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Provensis ltd
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Omega Pharmaceuticals
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. STD Pharmaceuticals Product Ltd
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Medtronic Plc
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Endo-Flex
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Boston Scientific Corporation
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. Teleflex Incorporated.
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表